A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin
- 28 May 1999
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 35 (3) , 253-255
- https://doi.org/10.1016/s0920-1211(99)00017-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998
- Genetic association between sensitivity to warfarin and expression of CYP2C9*3Pharmacogenetics, 1997
- Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant FormsArchives of Biochemistry and Biophysics, 1996
- The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphismPharmacogenetics, 1996
- Decreased Capacity to Metabolize Diphenylhydantoin in a Patient with Hypersensitivity to WarfarinAustralian and New Zealand Journal of Medicine, 1975